Snowden Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Sell |
3,957
-640
| -14% | -$285K | 0.05% | 340 |
|
|
2025
Q1 | $2.23M | Sell |
4,597
-143
| -3% | -$69.3K | 0.07% | 273 |
|
|
2024
Q4 | $1.91M | Sell |
4,740
-6,647
| -58% | -$2.68M | 0.06% | 315 |
|
|
2024
Q3 | $5.3M | Sell |
11,387
-2,606
| -19% | -$1.21M | 0.16% | 153 |
|
|
2024
Q2 | $6.56M | Sell |
13,993
-354
| -2% | -$166K | 0.2% | 119 |
|
|
2024
Q1 | $6M | Buy |
14,347
+250
| +2% | +$105K | 0.19% | 134 |
|
|
2023
Q4 | $5.74M | Buy |
14,097
+539
| +4% | +$219K | 0.22% | 118 |
|
|
2023
Q3 | $4.71M | Sell |
13,558
-84
| -0.6% | -$29.2K | 0.2% | 142 |
|
|
2023
Q2 | $4.8M | Buy |
13,642
+364
| +3% | +$128K | 0.17% | 157 |
|
|
2023
Q1 | $4.18M | Sell |
13,278
-69
| -0.5% | -$21.7K | 0.16% | 162 |
|
|
2022
Q4 | $3.85M | Buy |
13,347
+8,535
| +177% | +$2.46M | 0.16% | 156 |
|
|
2022
Q3 | $1.39M | Sell |
4,812
-323
| -6% | -$93.5K | 0.06% | 336 |
|
|
2022
Q2 | $1.45M | Buy |
5,135
+1,193
| +30% | +$336K | 0.06% | 323 |
|
|
2022
Q1 | $1.03M | Buy |
3,942
+3,573
| +968% | +$932K | 0.04% | 424 |
|
|
2021
Q4 | $81K | Sell |
369
-3,515
| -90% | -$772K | ﹤0.01% | 905 |
|
|
2021
Q3 | $705K | Buy |
3,884
+2,202
| +131% | +$399K | 0.04% | 450 |
|
|
2021
Q2 | $339K | Buy |
1,682
+533
| +46% | +$107K | 0.02% | 669 |
|
|
2021
Q1 | $247K | Buy |
1,149
+202
| +21% | +$43.4K | 0.01% | 697 |
|
|
2020
Q4 | $224K | Buy |
947
+98
| +12% | +$23.2K | 0.01% | 606 |
|
|
2020
Q3 | $231K | Buy |
849
+2
| +0.2% | +$544 | 0.02% | 517 |
|
|
2020
Q2 | $246K | Sell |
847
-24
| -3% | -$6.97K | 0.02% | 494 |
|
|
2020
Q1 | $207K | Buy |
+871
| New | +$207K | 0.02% | 489 |
|